PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1887135
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1887135
Molecular Imaging Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of molecular imaging Market
The global molecular imaging market continues to advance as healthcare systems increasingly adopt precision diagnostic technologies to improve disease detection and treatment monitoring. According to the latest industry assessments, the market was valued at USD 2.19 billion in 2024 and is projected to grow to USD 2.32 billion in 2025, reaching USD 3.46 billion by 2032. This growth is attributed to rising chronic disease prevalence, technological innovations in PET and SPECT imaging, and expanding healthcare infrastructure in developed and emerging markets.
Market Insights and Key Growth Factors
Molecular imaging plays a crucial role in diagnosing complex diseases by visualizing biological processes at the cellular and molecular levels. Demand for advanced imaging systems continues to rise, primarily due to increasing cases of cancer, neurological disorders, and cardiovascular conditions. The National Cancer Institute (2024) anticipates 2.0 million new cancer cases in the U.S. in 2024, demonstrating the urgent need for improved diagnostic tools.
A significant driver for the market in 2024 and 2025 is the rapid growth of the geriatric population. The Pew Research Center (2024) reported that 62 million adults aged 65+ live in the U.S., expected to reach 84 million by 2054. This aging demographic is more susceptible to Alzheimer's disease, Parkinson's disease, and musculoskeletal conditions-further supporting the need for more PET and SPECT scanners worldwide.
Additionally, leading manufacturers such as GE Healthcare, Siemens Healthineers AG, Canon Medical, and Philips continue to invest in R&D, introducing advanced hybrid imaging systems such as PET/CT and SPECT/CT, which improve diagnostic accuracy and shorten scan times.
Market Restraints
Despite its significant benefits, molecular imaging technology involves high investment costs, limiting adoption in low- and middle-income regions. A new PET/CT scanner costs between USD 0.5 million and USD 5.0 million, creating a financial barrier for many healthcare facilities. Moreover, the growing market for refurbished equipment-priced significantly lower at USD 0.25 million to USD 0.45 million-poses strong competition for new system installations, especially in emerging markets.
Opportunities in Medical Applications
The expanding use of molecular imaging across cardiology, oncology, neurology, orthopedics, and gynecology offers substantial growth opportunities through 2032. Point-of-care molecular imaging is gaining adoption due to faster results and better accessibility. According to a 2021 NCBI survey, 93% of respondents in the U.S. believed POCT improved their care, encouraging more hospitals and diagnostic centers to invest in advanced scanners.
Personalized medicine and precision oncology are further accelerating the demand for molecular imaging. PET and SPECT scans enable real-time evaluation of treatment responses, allowing physicians to tailor therapies more effectively.
Segmentation Analysis
By Type
In 2024, Positron Emission Tomography (PET) was the leading segment, driven by increasing neurological and oncological cases. The WHO reported 1.48 PET scanners per million population in Canada, highlighting strong adoption rates. SPECT technology is expected to grow steadily through 2032 as manufacturers introduce more affordable and efficient systems.
By Application
The oncology segment dominated in 2024 due to an escalating global cancer burden. Orthopedic applications also expanded, supported by 3.6 million orthopedic injury-related hospital visits annually in the U.S. Neurology is anticipated to rise significantly through 2032 as chronic neurological disorders become more common.
By End-User
Diagnostic imaging centers are growing fastest due to greater patient preference for shorter wait times and advanced imaging options. The U.S. had about 19,000 imaging centers in 2023, showcasing the scale of this segment.
Regional Outlook
North America
The largest market in 2024, North America recorded USD 0.96 billion in molecular imaging value. Strong healthcare spending, early adoption of advanced technology, and leading manufacturers in the region support continued dominance through 2032.
Europe
Growth is driven by increasing PET/CT and SPECT installations and government support for imaging research. The Netherlands leads with 2.33 PET scanners per million population.
Asia Pacific
Expected to be the fastest-growing region, supported by rising healthcare investment and a large elderly population. China alone recorded 297 million people aged 60+ in 2023.
Conclusion
With market value rising from USD 2.19 billion in 2024 to USD 2.32 billion in 2025, and projected to reach USD 3.46 billion by 2032, the molecular imaging market is poised for substantial expansion. Advancements in PET and SPECT technology, increasing chronic disease prevalence, and strong demand for precision diagnostics will sustain growth over the forecast period.
a DETAILS
Segmentation By Type
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Others
By Application
- Cardiology
- Oncology
- Orthopedics
- Gynecology
- Neurology
- Others
By End-user
- Hospitals
- Specialty Clinics
- Diagnostic Imaging Centers
- Others
By Geography
- North America (By Type, Application, End-user, and Country)
- U.S.
- Canada
- Europe (By Type, Application, End-user, and Country/Sub-region)
- Germany
- U.K.
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Type, Application, End-user, and Country/Sub-region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Type, Application, End-user, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)
- GCC
- South Africa
- Rest of Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2023/2024
- 4.2. Technological Advancements in Molecular Imaging Equipment
- 4.3. Installed Base, Key Countries/Regions, 2023/2024
- 4.4. New Product Launches, Key Players
- 4.5. Key Industry Developments - Mergers, Acquisitions & Partnerships
- 4.6. Impact of COVID-19 on the Market
5. Global Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast - By Type
- 5.1.1. Positron Emission Tomography (PET)
- 5.1.2. Single-Photon Emission Computed Tomography (SPECT)
- 5.1.3. Others
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Cardiology
- 5.2.2. Oncology
- 5.2.3. Orthopedics
- 5.2.4. Gynecology
- 5.2.5. Neurology
- 5.2.6. Others
- 5.3. Market Analysis, Insights and Forecast - By End User
- 5.3.1. Hospitals
- 5.3.2. Specialty Clinics
- 5.3.3. Diagnostic Imaging Centers
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Positron Emission Tomography (PET)
- 6.1.2. Single-Photon Emission Computed Tomography (SPECT)
- 6.1.3. Others
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Cardiology
- 6.2.2. Oncology
- 6.2.3. Orthopedics
- 6.2.4. Gynecology
- 6.2.5. Neurology
- 6.2.6. Others
- 6.3. Market Analysis, Insights and Forecast - By End User
- 6.3.1. Hospitals
- 6.3.2. Specialty Clinics
- 6.3.3. Diagnostic Imaging Centers
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Positron Emission Tomography (PET)
- 7.1.2. Single-Photon Emission Computed Tomography (SPECT)
- 7.1.3. Others
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Cardiology
- 7.2.2. Oncology
- 7.2.3. Orthopedics
- 7.2.4. Gynecology
- 7.2.5. Neurology
- 7.2.6. Others
- 7.3. Market Analysis, Insights and Forecast - By End User
- 7.3.1. Hospitals
- 7.3.2. Specialty Clinics
- 7.3.3. Diagnostic Imaging Centers
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
8. Asia pacific Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Positron Emission Tomography (PET)
- 8.1.2. Single-Photon Emission Computed Tomography (SPECT)
- 8.1.3. Others
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Cardiology
- 8.2.2. Oncology
- 8.2.3. Orthopedics
- 8.2.4. Gynecology
- 8.2.5. Neurology
- 8.2.6. Others
- 8.3. Market Analysis, Insights and Forecast - By End User
- 8.3.1. Hospitals
- 8.3.2. Specialty Clinics
- 8.3.3. Diagnostic Imaging Centers
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.4.1. Japan
- 8.4.2. Australia
- 8.4.3. China
- 8.4.4. India
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Positron Emission Tomography (PET)
- 9.1.2. Single-Photon Emission Computed Tomography (SPECT)
- 9.1.3. Others
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Cardiology
- 9.2.2. Oncology
- 9.2.3. Orthopedics
- 9.2.4. Gynecology
- 9.2.5. Neurology
- 9.2.6. Others
- 9.3. Market Analysis, Insights and Forecast - By End User
- 9.3.1. Hospitals
- 9.3.2. Specialty Clinics
- 9.3.3. Diagnostic Imaging Centers
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
10. Middle East & Africa Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Positron Emission Tomography (PET)
- 10.1.2. Single-Photon Emission Computed Tomography (SPECT)
- 10.1.3. Others
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Cardiology
- 10.2.2. Oncology
- 10.2.3. Orthopedics
- 10.2.4. Gynecology
- 10.2.5. Neurology
- 10.2.6. Others
- 10.3. Market Analysis, Insights and Forecast - By End User
- 10.3.1. Hospitals
- 10.3.2. Specialty Clinics
- 10.3.3. Diagnostic Imaging Centers
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2024)
- 11.2. Company Profiles
- 11.2.1. GE Healthcare
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Siemens Healthineers AG
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Koninklijke Philips N.V.
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Shimadzu Corporation
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. CANON MEDICAL SYSTEMS CORPORATION
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Bruker
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Lantheus Holdings, Inc.
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Segami Corporation
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.1. GE Healthcare
List of Tables
- Table 1: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
- Table 2: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
- Table 3: Global Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
- Table 4: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Region, 2019-2032
- Table 5: North America Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
- Table 6: North America Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
- Table 7: North America Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
- Table 8: North America Molecular Imaging Market Revenue (USD billion) Forecast, By Country, 2019-2032
- Table 9: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
- Table 10: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
- Table 11: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
- Table 12: Europe Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
- Table 13: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
- Table 14: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
- Table 15: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
- Table 16: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
- Table 17: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
- Table 18: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
- Table 19: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
- Table 20: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
- Table 21: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
- Table 22: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
- Table 23: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
- Table 24: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
List of Figures
- Figure 1: Global Molecular Imaging Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
- Figure 2: Global Molecular Imaging Market Value Share (%), by Type, 2024 & 2032
- Figure 3: Global Molecular Imaging Market Value Share (%), by Application, 2024 & 2032
- Figure 4: Global Molecular Imaging Market Value Share (%), by End User, 2024 & 2032
- Figure 5: Global Molecular Imaging Market Value Share (%), by Region, 2024 & 2032
- Figure 6: North America Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
- Figure 7: North America Molecular Imaging Market Value Share (%), by Type, 2024
- Figure 8: North America Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
- Figure 9: North America Molecular Imaging Market Value Share (%), by Application, 2024
- Figure 10: North America Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
- Figure 11: North America Molecular Imaging Market Value Share (%), by End User, 2024
- Figure 12: North America Molecular Imaging Market Value (USD billion), By Country, 2024 & 2032
- Figure 13: North America Molecular Imaging Market Value Share (%), By Country, 2024
- Figure 14: Europe Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
- Figure 15: Europe Molecular Imaging Market Value Share (%), by Type, 2024
- Figure 16: Europe Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
- Figure 17: Europe Molecular Imaging Market Value Share (%), by Application, 2024
- Figure 18: Europe Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
- Figure 19: Europe Molecular Imaging Market Value Share (%), by End User, 2024
- Figure 20: Europe Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 21: Europe Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2024
- Figure 22: Asia Pacific Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
- Figure 23: Asia Pacific Molecular Imaging Market Value Share (%), by Type, 2024
- Figure 24: Asia Pacific Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
- Figure 25: Asia Pacific Molecular Imaging Market Value Share (%), by Application, 2024
- Figure 26: Asia Pacific Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
- Figure 27: Asia Pacific Molecular Imaging Market Value Share (%), by End User, 2024
- Figure 28: Asia Pacific Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 29: Asia Pacific Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2024
- Figure 30: Latin America Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
- Figure 31: Latin America Molecular Imaging Market Value Share (%), by Type, 2024
- Figure 32: Latin America Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
- Figure 33: Latin America Molecular Imaging Market Value Share (%), by Application, 2024
- Figure 34: Latin America Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
- Figure 35: Latin America Molecular Imaging Market Value Share (%), by End User, 2024
- Figure 36: Latin America Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 37: Latin America Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2024
- Figure 38: Middle East & Africa Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
- Figure 39: Middle East & Africa Molecular Imaging Market Value Share (%), by Type, 2024
- Figure 40: Middle East & Africa Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
- Figure 41: Middle East & Africa Molecular Imaging Market Value Share (%), by Application, 2024
- Figure 42: Middle East & Africa Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
- Figure 43: Middle East & Africa Molecular Imaging Market Value Share (%), by End User, 2024
- Figure 44: Middle East & Africa Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 45: Middle East & Africa Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2024
- Figure 46: Global Molecular Imaging Market Share (%), By Company, 2024
